Icahn Carl’s Bausch Health BHC Stock Holding History

Icahn Carl’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-34,721,118	Closed	-$231M	–	14
2025 Q2	$231M	Hold	34,721,118	–	–	2.93%	6
2025 Q1	$225M	Hold	34,721,118	–	–	3%	6
2024 Q4	$280M	Hold	34,721,118	–	–	3.77%	6
2024 Q3	$283M	Hold	34,721,118	–	–	2.87%	5
2024 Q2	$242M	Hold	34,721,118	–	–	2.23%	6
2024 Q1	$368M	Hold	34,721,118	–	–	3.09%	5
2023 Q4	$278M	Hold	34,721,118	–	–	2.55%	5
2023 Q3	$285M	Hold	34,721,118	–	–	2.36%	6
2023 Q2	$278M	Hold	34,721,118	–	–	1.79%	7
2023 Q1	$281M	Hold	34,721,118	–	–	1.28%	8
2022 Q4	$218M	Hold	34,721,118	–	–	1%	9
2022 Q3	$239M	Hold	34,721,118	–	–	1.13%	11
2022 Q2	$290M	Hold	34,721,118	–	–	1.39%	10
2022 Q1	$793M	Hold	34,721,118	–	–	3.63%	5
2021 Q4	$959M	Buy	34,721,118 +611,966	+2%	+$16.4M	4.3%	5
2021 Q3	$950M	Hold	34,109,152	–	–	4.22%	6
2021 Q2	$1B	Hold	34,109,152	–	–	4.12%	6
2021 Q1	$1.08B	Buy	34,109,152 +29,076,005	+578%	+$853M	4.54%	6
2020 Q4	$105M	Buy	+5,033,147	New	+$93.9M	0.52%	15

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Icahn Carl's BHC Position: Q3 2025 in Review

Icahn Carl sold out of Bausch Health (BHC) in Q3 2025, closing a stake of 34,721,118 shares — an estimated $231M sold.

Icahn Carl first reported a position in BHC in Q4 2020 and held it in 19 quarters. The position peaked at $1.08B in Q1 2021. 219 funds tracked by Wall St. Rank hold BHC as of Q3 2025.

Icahn Carl reported no remaining Bausch Health position as of Q3 2025 after selling out during the quarter.
Icahn Carl sold 34,721,118 Bausch Health shares in Q3 2025, an estimated $231M.
Icahn Carl first reported a position in Bausch Health in Q4 2020 and held it in 19 quarters.
Icahn Carl's Bausch Health position peaked at $1.08B in Q1 2021.
219 funds tracked by Wall St. Rank held Bausch Health as of Q3 2025.

Based on Icahn Carl's 13F filing for Q3 2025, filed 14 Nov 2025.